Vistagen Therapeutics, Inc. (VTGN) › Total LiabilitiesVistagen Therapeutics, Inc. (VTGN) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2011: $18.67M2012: $6.05M2013: $13.44M2014: $13.06M2015: $20.81M2016: $3.97M2017: $3.10M2018: $4.36M2019: $6.94M2020: $11.50M2021: $16.30M2022: $9.93M2023: $9.01M2024: $9.37M2025: $13.95M2026: $13.04M$13.04M2011Total Liabilities (USD)2026Fiscal YearTotal LiabilitiesChange YoY2026$13.04M-6.5%2025$13.95M+48.9%2024$9.37M+4.0%2023$9.01M-9.3%2022$9.93M-39.1%2021$16.30M+41.7%2020$11.50M+65.8%2019$6.94M+59.0%2018$4.36M+40.9%2017$3.10M-21.9%2016$3.97M-80.9%2015$20.81M+59.3%2014$13.06M-2.8%2013$13.44M+122.2%2012$6.05M-67.6%2011$18.67M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share